Esperion Therapeutics
ESPR
#7380
Rank
โ‚ฌ0.35 B
Marketcap
1,78ย โ‚ฌ
Share price
-0.53%
Change (1 day)
-27.99%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -โ‚ฌ25.76 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.29 Billion. In 2023 the company made an earning of -โ‚ฌ0.15 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ25.76 Million-82.07%
2023 -โ‚ฌ0.15 Billion-15.03%
2022 -โ‚ฌ0.17 Billion-20.61%
2021 -โ‚ฌ0.22 Billion84.28%
2020 -โ‚ฌ0.12 Billion35.75%
2019 -โ‚ฌ85.12 Million-55.71%
2018 -โ‚ฌ0.2 Billion19.57%
2017 -โ‚ฌ0.17 Billion125.39%
2016 -โ‚ฌ71.31 Million51.43%
2015 -โ‚ฌ47.09 Million36.45%
2014 -โ‚ฌ34.52 Million43.55%
2013 -โ‚ฌ24.05 Million145.26%
2012 -โ‚ฌ9.81 Million
2002 -โ‚ฌ27.95 Million-7.81%
2001 -โ‚ฌ30.32 Million15.03%
2000 -โ‚ฌ26.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.48 Billion 1,617.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.37 B-1,455.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.63 B-24,136.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.75 B-17,304.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ65.34 Million 136.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.21 Billion 649.15%๐Ÿ‡บ๐Ÿ‡ธ USA